4//SEC Filing
Riggs Josh 4
Accession 0001493152-25-016291
CIK 0001642380other
Filed
Sep 29, 8:00 PM ET
Accepted
Sep 30, 4:05 PM ET
Size
5.9 KB
Accession
0001493152-25-016291
Insider Transaction Report
Form 4
Riggs Josh
CEO and President
Transactions
- Award
Option to Purchase Common Stock
2025-09-28+400,000→ 400,000 totalExercise: $3.33Exp: 2035-09-28→ Common Stock (400,000 underlying)
Footnotes (1)
- [F1]33 and 1/3% of the options will become exercisable after one year of continuous service from the effective date of grant, and the balance will become exercisable in 24 equal monthly installments commencing one year after the date of grant subject to continuous service through the applicable vesting date.
Documents
Issuer
Insight Molecular Diagnostics Inc.
CIK 0001642380
Entity typeother
Related Parties
1- filerCIK 0001956391
Filing Metadata
- Form type
- 4
- Filed
- Sep 29, 8:00 PM ET
- Accepted
- Sep 30, 4:05 PM ET
- Size
- 5.9 KB